Boston Scientific (BSX) Gross Profit Growth (3y) (2012 - 2026)
Boston Scientific (BSX) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 3.15% |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 8.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.44% |
| Dec 31, 2025 | 18.13% |
| Sep 30, 2025 | 17.36% |
| Jun 30, 2025 | 15.31% |
| Mar 31, 2025 | 15.73% |
| Dec 31, 2024 | 12.82% |
| Sep 30, 2024 | 12.55% |
| Jun 30, 2024 | 10.16% |
| Mar 31, 2024 | 12.54% |
| Dec 31, 2023 | 14.72% |
| Sep 30, 2023 | 10.67% |
| Jun 30, 2023 | 28.00% |
| Mar 31, 2023 | 10.58% |
| Dec 31, 2022 | 2.81% |
| Sep 30, 2022 | 4.32% |
| Jun 30, 2022 | 6.04% |
| Mar 31, 2022 | 5.51% |
| Dec 31, 2021 | 5.56% |
| Sep 30, 2021 | 5.71% |
| Jun 30, 2021 | 6.78% |